RxDoctor Payments Data

Marwah Elsehety, MD

Neurology · Leesburg, VANPI 1770011355

Payments from drug & device makers

What this record shows

This record is dominated by grants: $80,000 of the $80,490 with a category attached, or 99.4%. Biogen accounts for 99.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $80,153 and has fallen 99.8% since, to $134 in 2024. Among neurology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$80,490in general payments, 2019–2025

Across 16 payments — averaging $5030.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$80K
  • Medtronic$134
  • UCB, Inc.$119
  • Acorda Therapeutics, Inc$78
  • Amgen$49
  • Alnylam Pharmaceuticals Inc.$31
  • plus $35 from 2 others

What the payments were for

  • Speaking & faculty fees$650%
  • Grants$80,00099%
  • Food & beverage$4251%

General payments by program year

20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$80,490 in reported general payments places this provider in the 90th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia

Medicare billing

Part B allowed, 2024
$33,331
Medicare patients
193
Services billed
348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →